[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Opioid-induced Constipation Market Report 2018

March 2018 | 128 pages | ID: A215FEDA753QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Opioid-induced Constipation market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Opioid-induced Constipation for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Opioid-induced Constipation market competition by top manufacturers/players, with Opioid-induced Constipation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals International
  • Abbott
  • Bayer
  • Boehringer Ingelheim
  • C.B. Fleet
  • Cosmo Pharmaceuticals
  • Daewoong
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Ironwood Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Mundipharma
  • Nektar Therapeutics
  • Pfizer
  • Progenics Pharmaceuticals
  • Shionogi
  • SLA Pharma
  • Sucampo
  • Synergy Pharmaceuticals
  • Theravance
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Solid
  • Liquid
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Drugstore
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Opioid-induced Constipation Market Report 2018

1 OPIOID-INDUCED CONSTIPATION OVERVIEW

1.1 Product Overview and Scope of Opioid-induced Constipation
1.2 Classification of Opioid-induced Constipation by Product Category
  1.2.1 Asia-Pacific Opioid-induced Constipation Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Opioid-induced Constipation Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Solid
  1.2.4 Liquid
1.3 Asia-Pacific Opioid-induced Constipation Market by Application/End Users
  1.3.1 Asia-Pacific Opioid-induced Constipation Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 Asia-Pacific Opioid-induced Constipation Market by Region
  1.4.1 Asia-Pacific Opioid-induced Constipation Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Opioid-induced Constipation (2013-2025)
  1.5.1 Asia-Pacific Opioid-induced Constipation Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Opioid-induced Constipation Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC OPIOID-INDUCED CONSTIPATION COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Opioid-induced Constipation Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Opioid-induced Constipation Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Opioid-induced Constipation Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Opioid-induced Constipation (Volume and Value) by Type
  2.2.1 Asia-Pacific Opioid-induced Constipation Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Opioid-induced Constipation Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Opioid-induced Constipation (Volume) by Application
2.4 Asia-Pacific Opioid-induced Constipation (Volume and Value) by Region
  2.4.1 Asia-Pacific Opioid-induced Constipation Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Opioid-induced Constipation Revenue and Market Share by Region (2013-2018)

3 CHINA OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

3.1 China Opioid-induced Constipation Sales and Value (2013-2018)
  3.1.1 China Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  3.1.3 China Opioid-induced Constipation Sales Price Trend (2013-2018)
3.2 China Opioid-induced Constipation Sales Volume and Market Share by Type
3.3 China Opioid-induced Constipation Sales Volume and Market Share by Application

4 JAPAN OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Opioid-induced Constipation Sales and Value (2013-2018)
  4.1.1 Japan Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Opioid-induced Constipation Sales Price Trend (2013-2018)
4.2 Japan Opioid-induced Constipation Sales Volume and Market Share by Type
4.3 Japan Opioid-induced Constipation Sales Volume and Market Share by Application

5 SOUTH KOREA OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Opioid-induced Constipation Sales and Value (2013-2018)
  5.1.1 South Korea Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Opioid-induced Constipation Sales Price Trend (2013-2018)
5.2 South Korea Opioid-induced Constipation Sales Volume and Market Share by Type
5.3 South Korea Opioid-induced Constipation Sales Volume and Market Share by Application

6 TAIWAN OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Opioid-induced Constipation Sales and Value (2013-2018)
  6.1.1 Taiwan Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Opioid-induced Constipation Sales Price Trend (2013-2018)
6.2 Taiwan Opioid-induced Constipation Sales Volume and Market Share by Type
6.3 Taiwan Opioid-induced Constipation Sales Volume and Market Share by Application

7 INDIA OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

7.1 India Opioid-induced Constipation Sales and Value (2013-2018)
  7.1.1 India Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  7.1.3 India Opioid-induced Constipation Sales Price Trend (2013-2018)
7.2 India Opioid-induced Constipation Sales Volume and Market Share by Type
7.3 India Opioid-induced Constipation Sales Volume and Market Share by Application

8 SOUTHEAST ASIA OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Opioid-induced Constipation Sales and Value (2013-2018)
  8.1.1 Southeast Asia Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Opioid-induced Constipation Sales Price Trend (2013-2018)
8.2 Southeast Asia Opioid-induced Constipation Sales Volume and Market Share by Type
8.3 Southeast Asia Opioid-induced Constipation Sales Volume and Market Share by Application

9 AUSTRALIA OPIOID-INDUCED CONSTIPATION (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Opioid-induced Constipation Sales and Value (2013-2018)
  9.1.1 Australia Opioid-induced Constipation Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Opioid-induced Constipation Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Opioid-induced Constipation Sales Price Trend (2013-2018)
9.2 Australia Opioid-induced Constipation Sales Volume and Market Share by Type
9.3 Australia Opioid-induced Constipation Sales Volume and Market Share by Application

10 ASIA-PACIFIC OPIOID-INDUCED CONSTIPATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AstraZeneca
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Opioid-induced Constipation Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AstraZeneca Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Takeda Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Opioid-induced Constipation Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Takeda Pharmaceutical Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Valeant Pharmaceuticals International
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Opioid-induced Constipation Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Valeant Pharmaceuticals International Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Abbott
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Opioid-induced Constipation Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Abbott Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Bayer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Opioid-induced Constipation Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Bayer Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Opioid-induced Constipation Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Boehringer Ingelheim Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 C.B. Fleet
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Opioid-induced Constipation Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 C.B. Fleet Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Cosmo Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Opioid-induced Constipation Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Daewoong
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Opioid-induced Constipation Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Daewoong Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Daiichi Sankyo
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Opioid-induced Constipation Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Daiichi Sankyo Opioid-induced Constipation Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 GlaxoSmithKline
10.12 Ironwood Pharmaceuticals
10.13 Johnson & Johnson
10.14 Merck
10.15 Mundipharma
10.16 Nektar Therapeutics
10.17 Pfizer
10.18 Progenics Pharmaceuticals
10.19 Shionogi
10.20 SLA Pharma
10.21 Sucampo
10.22 Synergy Pharmaceuticals
10.23 Theravance

11 OPIOID-INDUCED CONSTIPATION MANUFACTURING COST ANALYSIS

11.1 Opioid-induced Constipation Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Opioid-induced Constipation

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Opioid-induced Constipation Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC OPIOID-INDUCED CONSTIPATION MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Opioid-induced Constipation Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Opioid-induced Constipation Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Opioid-induced Constipation Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Opioid-induced Constipation Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Opioid-induced Constipation Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Opioid-induced Constipation Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Opioid-induced Constipation Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Opioid-induced Constipation Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Opioid-induced Constipation Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Opioid-induced Constipation Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Opioid-induced Constipation Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Opioid-induced Constipation Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Opioid-induced Constipation Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Opioid-induced Constipation
Figure Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Volume Market Share by Type (Product Category) in 2017
Figure Solid Product Picture
Figure Liquid Product Picture
Figure Asia-Pacific Opioid-induced Constipation Sales (K Units) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Opioid-induced Constipation by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Opioid-induced Constipation Market Size (Million USD) by Region (2013-2025)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Opioid-induced Constipation Market Major Players Product Sales Volume (K Units)(2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Opioid-induced Constipation Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Opioid-induced Constipation Sales Share by Players/Suppliers
Figure Asia-Pacific Opioid-induced Constipation Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Opioid-induced Constipation Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Opioid-induced Constipation Revenue Share by Players
Figure 2017 Asia-Pacific Opioid-induced Constipation Revenue Share by Players
Table Asia-Pacific Opioid-induced Constipation Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales Share by Type (2013-2018)
Figure Sales Market Share of Opioid-induced Constipation by Type (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Opioid-induced Constipation by Type (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales Share by Region (2013-2018)
Figure Sales Market Share of Opioid-induced Constipation by Region (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Sales Market Share by Region in 2017
Table Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Opioid-induced Constipation by Region (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Revenue Market Share by Region in 2017
Table Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Asia-Pacific Opioid-induced Constipation Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Opioid-induced Constipation Sales Market Share by Application (2013-2018)
Figure China Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table China Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table China Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure China Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table China Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table China Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure China Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure Japan Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table Japan Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure Japan Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table Japan Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table Japan Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure Japan Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure South Korea Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure South Korea Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table South Korea Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table South Korea Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure South Korea Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table South Korea Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table South Korea Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure South Korea Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure Taiwan Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Taiwan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table Taiwan Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table Taiwan Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table Taiwan Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table Taiwan Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure India Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table India Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table India Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure India Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table India Opioid-induced Constipation Sales Volume (K Units) by Application (2013-2018)
Table India Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure India Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure Southeast Asia Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table Southeast Asia Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table Southeast Asia Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Figure Australia Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Australia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Opioid-induced Constipation Sales Price (USD/Unit) Trend (2013-2018)
Table Australia Opioid-induced Constipation Sales Volume (K Units) by Type (2013-2018)
Table Australia Opioid-induced Constipation Sales Volume Market Share by Type (2013-2018)
Figure Australia Opioid-induced Constipation Sales Volume Market Share by Type in 2017
Table Australia Opioid-induced Constipation Sales Volume (K Units) by Applications (2013-2018)
Table Australia Opioid-induced Constipation Sales Volume Market Share by Application (2013-2018)
Figure Australia Opioid-induced Constipation Sales Volume Market Share by Application in 2017
Table AstraZeneca Opioid-induced Constipation Basic Information List
Table AstraZeneca Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Takeda Pharmaceutical Opioid-induced Constipation Basic Information List
Table Takeda Pharmaceutical Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Valeant Pharmaceuticals International Opioid-induced Constipation Basic Information List
Table Valeant Pharmaceuticals International Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Abbott Opioid-induced Constipation Basic Information List
Table Abbott Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Abbott Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Abbott Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Bayer Opioid-induced Constipation Basic Information List
Table Bayer Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Bayer Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Boehringer Ingelheim Opioid-induced Constipation Basic Information List
Table Boehringer Ingelheim Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table C.B. Fleet Opioid-induced Constipation Basic Information List
Table C.B. Fleet Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Cosmo Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Cosmo Pharmaceuticals Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Daewoong Opioid-induced Constipation Basic Information List
Table Daewoong Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daewoong Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Daewoong Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Daewoong Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table Daiichi Sankyo Opioid-induced Constipation Basic Information List
Table Daiichi Sankyo Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Sales (K Units) and Growth Rate (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Sales Market Share in Asia-Pacific (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Revenue Market Share in Asia-Pacific (2013-2018)
Table GlaxoSmithKline Opioid-induced Constipation Basic Information List
Table Ironwood Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Johnson & Johnson Opioid-induced Constipation Basic Information List
Table Merck Opioid-induced Constipation Basic Information List
Table Mundipharma Opioid-induced Constipation Basic Information List
Table Nektar Therapeutics Opioid-induced Constipation Basic Information List
Table Pfizer Opioid-induced Constipation Basic Information List
Table Progenics Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Shionogi Opioid-induced Constipation Basic Information List
Table SLA Pharma Opioid-induced Constipation Basic Information List
Table Sucampo Opioid-induced Constipation Basic Information List
Table Synergy Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Theravance Opioid-induced Constipation Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-induced Constipation
Figure Manufacturing Process Analysis of Opioid-induced Constipation
Figure Opioid-induced Constipation Industrial Chain Analysis
Table Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
Table Major Buyers of Opioid-induced Constipation
Table Distributors/Traders List
Figure Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Price (USD/Unit) and Trend Forecast (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Sales Volume (K Units) Forecast by Region (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Opioid-induced Constipation Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue Market Share Forecast by Region in 2025
Figure China Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure South Korea Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Taiwan Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Opioid-induced Constipation Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Australia Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Sales (K Units) Forecast by Type (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Price (USD/Unit) Forecast by Type (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Sales (K Units) Forecast by Application (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories